Recognition and Treatment of Depressive Symptoms in Parkinson's Disease: the NPF Dataset
Overview
Affiliations
Depression is a major determinant of Health Related Quality of Life in PD, but there is limited data on physician recognition of depression and treatment efficacy. We used data obtained from the QII dataset of the National Parkinson's Foundation database to determine whether there was an association between depressive symptoms and utilization of antidepressants and/or mental health services (MHS) in a large cohort of PD patients. We found that prevalence of depressive symptoms remained high in the PD population despite improved physician recognition and treatment initiation.
Improving Parkinson's Disease Care through Systematic Screening for Depression.
Marras C, Meyer Z, Liu H, Luo S, Mantri S, Allen A Mov Disord Clin Pract. 2024; 11(10):1212-1222.
PMID: 39030949 PMC: 11489616. DOI: 10.1002/mdc3.14163.
Exploring Treatment for Depression in Parkinson's Patients: A Cross-Sectional Analysis.
DeMarco E, Al-Hammadi N, Hinyard L Int J Environ Res Public Health. 2021; 18(16).
PMID: 34444343 PMC: 8392211. DOI: 10.3390/ijerph18168596.
Orayj K Neuropsychiatr Dis Treat. 2021; 17:2499-2510.
PMID: 34354357 PMC: 8331107. DOI: 10.2147/NDT.S325521.
Orayj K, Almeleebia T, Vigneshwaran E, Alshahrani S, Alavudeen S, Alghamdi W Brain Behav. 2021; 11(8):e2228.
PMID: 34124851 PMC: 8413829. DOI: 10.1002/brb3.2228.
Abraham D, Pham Nguyen T, Hennessy S, Gray S, Xie D, Weintraub D Am J Geriatr Psychiatry. 2020; 29(1):35-47.
PMID: 32553997 PMC: 7671949. DOI: 10.1016/j.jagp.2020.05.014.